Acute human immunodeficiency virus infection

American Journal of the Medical Sciences

Volumn 345, Issue 2, 2013, Pages 136-142

  Richey, Lauren E ^a   Halperin, Jason ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute HIV; Acute retroviral syndrome; AIDS; HIV; Primary HIV

Indexed keywords

ANTIGEN P24; GAG PROTEIN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; PROTEIN P17; PROTEIN P51; PROTEIN P55; PROTEIN P66; VIRUS RNA;

ANTIVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CYTOKINE STORM; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LANGERHANS CELL; NEUROLOGICAL COMPLICATION; OPPORTUNISTIC INFECTION; PATIENT CARE; PUBLIC HEALTH PROBLEM; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEROCONVERSION; UNITED STATES; VIRUS LOAD; VIRUS REPLICATION; WESTERN BLOTTING;

EID: 84873114173     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31825d4b88     Document Type: Review

References (83)

1. UNAIDS. Global report 2010. Geneva, Switzerland: UNAIDS; 2010 Available at: Http://www.unaids.org/globalreport/documents/20101123-GlobalReport-full-en. pdf. Accessed February 11, 2012
2. CDC. HIV surveillance report, 2009; vol. 21. Available at: Http://www. cdc.gov/hiv/topics/surveillance/resources/reports/. Accessed February 11, 2012
3. CDC. HIV in the United States fact sheet. August 2011. Available at: Http://www.cdc.gov/hiv/resources/factsheets/PDF/us.pdf. Accessed February 11, 2012
4. Prejean J, Song R, Hernandez A, et al. Estimated HIV incidence in the United States, 2006-2009. PLoS One 2011;6:e17502
5. Braunstein SL, Shepard CW. The potential pitfalls of targeted screening for acute HIV infections: The view from New York City. J Infect Dis 2011;204:487-8
6. Hightow-Weidman LB, Golin CE, Green K, et al. Identifying people with acute HIV infection (AHI) - demographic features, risk factors, and use of health care among individuals with AHI in North Carolina. AIDS Behav 2009;13:1075-83
7. Pincus JM, Crosby SS, Losina E, et al. Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center. Clin Infect Dis 2003;37:1699-704
8. Bebell LM, Pilcher CD, Dorsey G, et al. Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria. AIDS 2010; 24:1945-52
9. Rosenberg ES, Caliendo AM, Walker BD. Acute HIV infection among patients tested for mononucleosis. N Engl J Med 1999;340:969
10. Kahn JA, Walker BR. Acute human immunodeficiency virus type 1 infection. N Engl J Med 1998;339:133-9
11. Self WH. Acute HIV infection: Diagnosis and management in the emergency department. Emerg Med Clin N Am 2010;28:381-92
12. Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-70
13. Lindback S, Karlsson AC, Mittler J, et al. Viral dynamics in primary HIV-1 infection. Karolinska Institutet Primary HIV Infection Study Group. AIDS 2000;14:2283-91
14. Stacey AR, Norris PJ, Qin L, et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 2009;83:3719-33
15. Buchacz K, Hu DJ, Vanichseni S, et al. Early markers of HIV-1 disease progression in a prospective cohort of seroconverters in Bangkok, Thailand: Implications for vaccine trials. J Acquir Immune Defic Syndr 2004;36:853-60
16. Cooper DA, Gold I, MacLean P, et al. Acute AIDS retrovirus infection: Definition of a clinical illness associated with seroconversion. Lancet 1985;1:537-40
17. Montessori V, Rouleau D, Raboud J, et al. Clinical characteristics of primary HIV infection in injection drug users. AIDS 2000;14:1868-70
18. Niu MT, Stein DS, Schnittman SM. Primary human immunodeficiency virus type 1 infection: Review of pathogenesis and early treatment intervention in human and animal retrovirus infections. J Infect Dis 1993;168:1490-1501
19. Pilcher CD, Eron JJ Jr, Galvin S, et al. Acute HIV revisited: New opportunities for treatment and prevention. J Clin Invest 2004;113:937-45
20. Kaufmann GR, Duncombe C, Zaunders J, et al. Primary HIV-1 infection: A review of clinical manifestations, immunologic and virologic changes. AIDS Patient Care STDs 1998;12:759-67
21. Schacker TI, Collier AN, Hughes JA, et al. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996;125:257-64
22. Varma VA, Hunter S, Tickman R, et al. Acute fatal HIV encephalitis with negative serologic assays for antibody and antigen: Diagnosis by polymerase chain reaction. N Engl J Med 1989;320:1494-5
23. Umgelter A, Huber W, Schmid RM, et al. Coma as a presenting symptom of primary HIV infection. Sex Transm Infect 2007;83:85-6
24. Socías ME, Sued O, Laufer N, et al. Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters. J Int AIDS Soc 2011;14:40
25. Lavreys L, Thompson ML, Martin HL Jr, et al. Primary human immunodeficiency virus type 1 infections: Clinical manifestations among women in Mombasa, Kenya. Clin Infect Dis 2000;30:486-90
26. Lapins J, Gaines H, Lindba S, et al. Skin and mucosal characteristics of symptomatic primary HIV-1 infection. AIDS Patient Care STDs 2009;11:67-70
27. Tindall B, Barker S, Donovan B, et al. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med 1988;148:945-9
28. Hanson KI, Reckleff JE, Hicks LA, et al. Unsuspected HIV infection in patients presenting with acute meningitis. Clin Infect Dis 2008;47:433-4
29. Duovoyiannis MI, Litman NA. Acute encephalopathy and multi-organ involvement with rhabdomyolysis during primary HIV infection. Int J Infect Dis 2009;13:e299-304
30. Ayarza A, Parisi V, Altclas V, et al. Opsoclonus-myoclonus-ataxia syndrome and HIV seroconversion. J Neurol 2009;256:1024-5
31. Kapoor R, Griffin G, Barrett G, et al. Myoclonic epilepsy in an HIV positive patient: Neurophysiological findings. Electroencephalogr Clin Neurophysiol 1991;78:80-4
32. Halperin J, Richey L, Mushatt D. The modern day masquerader: A rare case of acute HIV infection with neurologic complications and a review of the literature. J La State Med Soc 2012;164:76-80
33. Tattevin P, Camus C, Arvieux C, et al. Multiple organ failure during primary HIV infection. Clin Infect Dis 2007;44:e28-9
34. McDonagh CA, Holman RP. Primary human immunodeficiency virus type 1 infection in a patient with acute rhabdomyolysis. South Med J 2003;96:1027-30
35. Delo D, Brett A, Postic B, et al. Primary HIV infection presenting with acute rhabdomyolysis. Am J Med Sci 2006;332:46-47
36. Prabahar MR, Jain M, Chandrasekaran V, et al. Primary HIV infection presenting as non-traumatic rhabdomyolysis with acute renal failure. Saudi J Kidney Dis Transpl 2008;19:636-42
37. Pano-Pardo JR, Alcaide ML, Abbo L, et al. Primary HIV infection with multisystemic presentation. Int J Infect Dis 2009;13:e177-80
38. Szabo S, James CW, Telford G. Unusual presentations of primary human immunodeficiency virus infection. AIDS Patient Care STDs 2002;16:251-4
39. Byers DK, Decker CF. Unusual case of Pneumocystis jiroveci pneumonia during primary HIV infection. AIDS Read 2008;18:313-7
40. Pena JM, Martinez-Lopez MA, Arnalich F, et al. Esophageal candidiasis associated with acute infection due to human immunodeficiency virus: Case report and review. Rev Infect Dis 1991;13:872-5
41. Signorini L, Gulletta M, Coppini D, et al. Fatal disseminated toxoplasmosis during primary HIV infection. Curr HIV Res 2007;5:273-4
42. Vento S, Di Perri G, Garofano T, et al. Pneumocystis carinii pneumonia during primary HIV-1 infection. Lancet 1993;342:24-5
43. Tindall B, Hing M, Edwards P, et al. Severe clinical manifestations of primary HIV infection. AIDS 1989;3:747-9
44. Wawer M, Gray R, Sweankambo N, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005;191:1403-9
45. Quinn TC. Acute primary HIV infection. J Am Med Assoc 1997;278: 58-62
46. Brenner BG, Roger M, Routy JP, et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007;195:951-9
47. Koopman JS, Jacquez JA, Welch GW, et al. The role of the early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:249-58
48. Colfax GN, Buchbinder SP, Cornelisse PG, et al. Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. AIDS 2002;16:1529-35
49. Pilcher CD, Shugars DC, Fiscus SA, et al. HIV in body fluids during primary HIV infection: Implications for pathogenesis, treatment, and public health. AIDS 2001;15:837-45
50. Pilcher CD, Tien CH, Eron JJ, et al. Brief but efficient: Acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004;18:1785-92
51. Marks G, Crepaz N, Senterfitt JW, et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States. J Acquir Immune Defic Syndr 2005;39:446-53
52. Kelley CF, Barbour JD, Hecht FM. The relation between symptoms, viral load, and viral load set point in primary HIV infection. J Acquir Immune Defic Syndr 2007;45:445-8
53. Weintrob AC, Giner J, Menezes P, et al. Infrequent diagnosis of primary human immunodeficiency virus infection. Arch Intern Med 2003;163:2097-100
54. Fiebig E, Wright D, Rawal B, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary HIV infection. AIDS 2003;17:1871-9
55. Li Q, Skinner PJ, Ha SJ, et al. Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science 2009;323:1726-9
56. Cohen MS, Gay CL, Busch MP, et al. The detection of acute HIV infection. J Infect Dis 2010;20:S270-7
57. Bartlett JG, Gallant JE, Pham PA. Medical management of HIV infection 2009-2010. Durham (NC): Knowledge Source Solution; 2009
58. Eshleman SH, Khaki L, Laeyendecker O, et al. Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV ag/ab combo assay. J Acquir Immune Defic Syndr 2009;52:121-4
59. Rosenberg NE, Kamanga G, Phiri S, et al. Detection of acute HIV infection: A field evaluation of the determine HIV-1/2 Ag/Ab combo test. J Infect Dis 2012;205:528-34
60. Pilcher CD, Fiscus SA, Nguyen TQ, et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005;352:1873-83
61. Miller WC, Leone PA, McCoy S, et al. Targeted testing for acute HIV infection in North Carolina. AIDS 2009;23:835-43
62. Branson BM, Handsfield HH, Landsfield MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006;55:1-17
63. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. p. 1-239 Available at: Http://www.aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Accessed March 28, 2012
64. Gazzard BG, Anderson J, Babiker A, et al. British HIV association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med 2008;9:563-608
65. Bell SK, Little SJ, Rosenberg ES. Clinical management of acute HIV infection: Best practice remains unknown. J Infect Dis 2010;202: S278-88
66. Rosenberg ES, Altfeld M, Poon SH, et al. Immune control of HIV-1 after early treatment of acute infection. Nature 2000;407:523-6
67. Hicks CB, Gay C, Ferrari G. Acute HIV infection: The impact of antiretroviral treatment on cellular immune responses. Clin Exp Immunol 2007;149:211-6
68. Koegl C, Wolf E, Hanhoff N, et al. Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort. Eur J Med Res 2009;14:277-83
69. Fidler S, Fox J, Touloumi G, et al. Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: Findings from an observational cohort. AIDS 2007;21:1283-91
70. Hecht F, Wang L, Collier A, et al. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis 2006;194:725-33
71. Hogan CM, DeGruttola V, Sun X, et al. The setpoint study (ACTG A5217): Effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. J Infect Dis 2012;205:87-96
72. Ray M, Logan R, Sterne JA, et al. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS 2010;24:123-37
73. Cu-Uvin S, Caliendo AM, Reinert S, et al. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS 2000;14:415-21
74. Nagot N, Quedraogo A, Weiss HA, et al. Longitudinal effect following initiation of highly active antiretroviral therapy on plasma and cervico- vaginal HIV-1 RNA among women in Burkina Faso. Sex Transm Infect 2008;84:167-17
75. Al-Harthi L, Kovacs A, Coombs RW, et al. A menstrual cycle pattern for cytokine levels exists in HIV-positive women: Implication for HIV vaginal and plasma shedding. AIDS 2001;15:1535-43
76. CohenMS, Chen YQ,McCauleyM, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505
77. Hoen B, Cooper D, Lampe F, et al. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GWPROB3005. Clin Infect Dis 2007;45:381-90
78. Amico KR. Standard of care for antiretroviral therapy adherence and retention in care from the perspective of care providers attending the 5th International Conference on HIV Treatment Adherence. J Int Assoc Physicians AIDS Care 2011;10:291-6
79. Little SJ, Holte S, Routy JP, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002;347:385-94
80. Kim D, Wheeler W, Ziebell R, et al. US variant, atypical, and resistant HIV surveillance coordinators. Prevalence of transmitted antiretroviral drug resistance among newly-diagnosed HIV-1-infected persons, US, 2007
81. Presented at: 17th Conference on Retroviruses and Opportunistic Infections. San Francisco (CA); February 16 - 19, 2010. http://retroconference. org/2010/Abstracts/38109.htm. Accessed May 17, 2011
82. Aberg JA, Gallant JE, Anderson J, et al. Primary care guidelines for the management of person infected with human immunodeficiency virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2004;39: 609-29
83. Hirsch MS, Gunthard HF, Schapiro JM, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis 2008;47: 266-85.